Quercetin is a polyphenol compound that possesses anti-inflammatory properties and can be found in various food sources like apples, berries, cabbage, and onions. In Park et al.'s study, it was discovered that quercetin led to a significant decrease in the proliferation of endometriosis cells. Furthermore, quercetin also triggered apoptosis in endometriosis cells in vitro and reduced the size of endometriosis lesions in vivo. Nevertheless, as of now, there have been no studies conducted in Iran or worldwide that explore the effects of quercetin supplementation on individuals with endometriosis. Hence, the aim of this study is to investigate the impact of quercetin supplementation on factors such as glycemic status, lipid profile, oxidative stress, inflammation, growth factors, adiponectin, sex hormones, and anthropometric indicators in women suffering from endometriosis.
The participants in the study were randomly assigned to two groups: the intervention group and the control group. The intervention group will receive two 500 mg quercetin tablets daily, after breakfast and lunch, for twelve weeks. On the other hand, the control group will be given a placebo. Blood samples will be collected before and after the intervention to measure changes in blood lipid profile, fasting blood sugar, sex hormones (testosterone, estrogen, progesterone), TNFα, IL-6, adiponectin, IGF1, HbA1C, SHBG, FSH, LH, and plasma total antioxidant capacity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
50
National Nutrition and Food Technology Research Institute
Tehran, Iran
RECRUITINGMean serum TNF-alpha concentration
Human Tumor Necrosis Factor Αlpha, TNF-A ELISA Kit
Time frame: 12 weeks
Mean serum IL-6 concentration
Human Interleukin 6, IL-6 ELISA Kit
Time frame: 12 weeks
Mean Serum FBS concentration
Glucose Test Kit
Time frame: 12 weeks
Mean HbA1C Serum
Human Hemoglobin A1c (HbA1c) Assay Kit
Time frame: 12 weeks
Mean Serum Testosterone concentration
The Testosterone ELISA Kits
Time frame: 12 weeks
Mean Serum Estrogen concentration
The Total Estrogens ELISA Assay Kit
Time frame: 12 weeks
Mean Serum Adiponectin concentration
Adiponectin Human ELISA Kit
Time frame: 12 weeks
Mean Serum IGF1 concentration
IGF-1 ELISA Assay Kit
Time frame: 12 weeks
Mean Serum SHBG concentration
liquid chromatography-tandem mass spectrometry
Time frame: 12 weeks
Mean Serum FSH concentration
FSH (Human) ELISA Kit
Time frame: 12 weeks
Mean Serum LH concentration
LH (Human) ELISA Kit
Time frame: 12 weeks
Mean Serum Progesterone concentration
The Progesterone Enzyme Immunoassay Kit
Time frame: 12 weeks
Mean plasma total antioxidant capacity concentration
Total Antioxidant Capacity ELISA Kit
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.